- Home
- XOMA vs SOPH Comparison
XOMA vs SOPH Comparison
Compare XOMA & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XOMA
- SOPH
- Stock Information
- Founded
- XOMA 1981
- SOPH 2011
- Country
- XOMA United States
- SOPH Switzerland
- Employees
- XOMA N/A
- SOPH N/A
- Industry
- XOMA Biotechnology: Pharmaceutical Preparations
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- XOMA Health Care
- SOPH Health Care
- Exchange
- XOMA Nasdaq
- SOPH Nasdaq
- Market Cap
- XOMA 320.8M
- SOPH 247.0M
- IPO Year
- XOMA N/A
- SOPH 2021
- Fundamental
- Price
- XOMA $28.59
- SOPH $3.40
- Analyst Decision
- XOMA Strong Buy
- SOPH Strong Buy
- Analyst Count
- XOMA 2
- SOPH 3
- Target Price
- XOMA $78.50
- SOPH $7.00
- AVG Volume (30 Days)
- XOMA 18.9K
- SOPH 21.9K
- Earning Date
- XOMA 11-05-2024
- SOPH 11-05-2024
- Dividend Yield
- XOMA N/A
- SOPH N/A
- EPS Growth
- XOMA N/A
- SOPH N/A
- EPS
- XOMA N/A
- SOPH N/A
- Revenue
- XOMA $15,239,000.00
- SOPH $64,938,000.00
- Revenue This Year
- XOMA $456.45
- SOPH $7.70
- Revenue Next Year
- XOMA $29.84
- SOPH $20.61
- P/E Ratio
- XOMA N/A
- SOPH N/A
- Revenue Growth
- XOMA 277.95
- SOPH 20.14
- 52 Week Low
- XOMA $14.27
- SOPH $2.70
- 52 Week High
- XOMA $30.50
- SOPH $7.37
- Technical
- Relative Strength Index (RSI)
- XOMA 53.55
- SOPH 44.10
- Support Level
- XOMA $28.66
- SOPH $3.22
- Resistance Level
- XOMA $30.50
- SOPH $3.66
- Average True Range (ATR)
- XOMA 1.07
- SOPH 0.20
- MACD
- XOMA 0.21
- SOPH 0.01
- Stochastic Oscillator
- XOMA 55.56
- SOPH 58.60
About XOMA XOMA Corporation
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.